FDA Approves Keppra InjectionKeppra Injection is an intravenous formulation of levetiracetam providing an alternative for patients when oral administration is temporarily not feasible. Keppra Injection is indicated for use as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy.
Posted: July 2006
- UCB Announces FDA Approval for Keppra in Infants and Children from One Month of Age with Partial Onset Seizures - January 25, 2012
- Keppra XR Approved in the U.S. - September 15, 2008